Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo. 2018

Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
Tianjin Key Lab of Radiation Medicine Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China. wangqin@irm-cams.ac.cn.

Colorectal cancer is the most commonly reported gastrointestinal malignancy, with a recent, rapid increase of the annual incidence all over the world. Enhancing the radiosensitivity of cancer cells while preserving the health of normal cells is one of the most important tasks in clinical radiobiology. However, resistance to radiotherapy for colorectal cancer greatly decreases the therapeutic outcome. Melatonin (N-acetyl-5-methoxytryptamine), a natural secretory product that the pineal gland in the brain normally produces, has been reported to have anticancer properties. In the study, we investigated the combination of melatonin with radiotherapy as a treatment for colorectal cancer. We firstly explored the anti-tumor activity of melatonin combined with ionizing radiation (IR) against colorectal carcinoma in vitro. It was found that melatonin effectively inhibited human colorectal carcinoma cell line HCT 116 cellular proliferation, colony formation rate and cell migration counts following IR. Increasing the radiosensitivity of colorectal cancer cells by melatonin treatment was found to be associated with cell cycle arrest in the G2/M phase, downregulation of proteins involved in DNA double-strand break repair and activation of the caspase-dependent apoptotic pathway. Moreover, we also investigated the combined effect of IR and melatonin on colorectal tumor in vivo. Results from a tumor xenograft showed that melatonin plus IR treatment significantly suppressed tumor cell growth compared with melatonin or IR alone, resulting in a much higher tumor inhibition rate for the combined treatment. The data suggested that melatonin combined with IR could improve the radiosensitivity of colorectal cancer and thus enhance the therapeutic effect of the patients, implying melatonin could function as a potential sensitizer in tumor radiotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
March 2017, Cancer letters,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
February 2024, Cell cycle (Georgetown, Tex.),
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
November 2011, Radiation oncology (London, England),
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
December 2016, Oncotarget,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
January 2005, Breast cancer research : BCR,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
March 2015, Journal of pineal research,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
July 2004, Journal of experimental therapeutics & oncology,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
January 2015, The Prostate,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
October 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
Qin Wang, and Zhijuan Sun, and Liqing Du, and Chang Xu, and Yan Wang, and Bing Yang, and Ningning He, and Jinhan Wang, and Kaihua Ji, and Yang Liu, and Qiang Liu
January 2020, Iranian journal of pharmaceutical research : IJPR,
Copied contents to your clipboard!